quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:19:36·53d
SECFiling
Sionna Therapeutics Inc. logo

SEC Form 10-K filed by Sionna Therapeutics Inc.

SION· Sionna Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • SION
    Sionna Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Feb 24UpdateCitizens$63.00
  • Dec 1UpdateRBC Capital Mkts$24.00
  • Nov 19UpdateBTIG Research$50.00
  • Sep 3UpdateRaymond James$45.00
  • Sep 3UpdateRBC Capital Mkts$22.00
  • Mar 4UpdateTD Cowen-

Related

  • INSIDER2d
    SEC Form 4 filed by Thompson Peter A.
  • INSIDER2d
    SEC Form 4 filed by Orbimed Advisors Llc
  • SEC3d
    Amendment: SEC Form SCHEDULE 13D/A filed by Sionna Therapeutics Inc.
  • INSIDER7d
    SEC Form 4 filed by Thompson Peter A.
  • INSIDER7d
    SEC Form 4 filed by Orbimed Advisors Llc
  • PR17d
    Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
  • INSIDER48d
    Chief Legal Officer Fitzpatrick Jennifer exercised 10,250 shares at a strike of $6.11 and sold $347,019 worth of shares (10,250 units at $33.86) (SEC Form 4)
  • SEC53d
    SEC Form S-8 filed by Sionna Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022